The Filings Report

Albemarle Corporation

ALBNYSECIK 915913Basic Materials / Chemicalsfiscal year ends December69 quarters since 2009

Revenue, Q2 FY2026
$1.7B
+31.1% on Q2 FY2025
Net income
$480M
+1996.2% on Q2 FY2025
Free cash flow
$638M
+596.1% on Q2 FY2025
Diluted EPS
$3.52
+2300.0% on Q2 FY2025
Revenue, TTM
$5.9B
trailing four quarters
Net margin, TTM
3.8%
net income $224M
Free cash flow, TTM
$1.3B
$1.8B less $458M capex
Cash and equivalents
$1.6B
long-term debt $1.8B, Jun 30, 2026
Shares, 12-month change
+0.3%
118M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$191M
1.8% of market value
Market value
$10.7B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Albemarle Corporation reported revenue of $1.7B, +31.1% on Q2 FY2025, and net income of $480M (+1996.2%). Operating margin was 26.0%. Free cash flow, operating cash flow less capital expenditures, was $638M ($710M less $72M). Diluted earnings per share were $3.52.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 5, 2026.

Revenue and net incomeRevenueNet income
−$2B−$1B$0$1B$2B$3BQ3'22, Revenue: $2.1BQ3'22, Net income: $897MQ3'22Q4'22, Revenue: $2.6BQ4'22, Net income: $1.1BQ4'22Q1'23, Revenue: $2.6BQ1'23, Net income: $1.2BQ1'23Q2'23, Revenue: $2.4BQ2'23, Net income: $650MQ2'23Q3'23, Revenue: $2.3BQ3'23, Net income: $303MQ3'23Q4'23, Revenue: $2.4BQ4'23, Net income: −$618MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $2MQ1'24Q2'24, Revenue: $1.4BQ2'24, Net income: −$188MQ2'24Q3'24, Revenue: $1.4BQ3'24, Net income: −$1.1BQ3'24Q4'24, Revenue: $1.2BQ4'24, Net income: $75MQ4'24Q1'25, Revenue: $1.1BQ1'25, Net income: $41MQ1'25Q2'25, Revenue: $1.3BQ2'25, Net income: $23MQ2'25Q3'25, Revenue: $1.3BQ3'25, Net income: −$161MQ3'25Q4'25, Revenue: $1.4BQ4'25, Net income: −$414MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $319MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $480MQ2'26−$2B−$1B$0$1B$2B$3BQ3'22, Revenue: $2.1BQ3'22, Net income: $897MQ4'22, Revenue: $2.6BQ4'22, Net income: $1.1BQ4'22Q1'23, Revenue: $2.6BQ1'23, Net income: $1.2BQ2'23, Revenue: $2.4BQ2'23, Net income: $650MQ2'23Q3'23, Revenue: $2.3BQ3'23, Net income: $303MQ4'23, Revenue: $2.4BQ4'23, Net income: −$618MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $2MQ2'24, Revenue: $1.4BQ2'24, Net income: −$188MQ2'24Q3'24, Revenue: $1.4BQ3'24, Net income: −$1.1BQ4'24, Revenue: $1.2BQ4'24, Net income: $75MQ4'24Q1'25, Revenue: $1.1BQ1'25, Net income: $41MQ2'25, Revenue: $1.3BQ2'25, Net income: $23MQ2'25Q3'25, Revenue: $1.3BQ3'25, Net income: −$161MQ4'25, Revenue: $1.4BQ4'25, Net income: −$414MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $319MQ2'26, Revenue: $1.7BQ2'26, Net income: $480MQ2'26

Net income losses drawn in red.

Free cash flow
−$1.0B−$500M$0$500M$1.0BQ3'22, Free cash flow: $582MQ3'22Q4'22, Free cash flow: $507MQ4'22Q1'23, Free cash flow: $305MQ1'23Q2'23, Free cash flow: −$430MQ2'23Q3'23, Free cash flow: $83MQ3'23Q4'23, Free cash flow: −$786MQ4'23Q1'24, Free cash flow: −$486MQ1'24Q2'24, Free cash flow: −$84MQ2'24Q3'24, Free cash flow: −$76MQ3'24Q4'24, Free cash flow: −$347MQ4'24Q1'25, Free cash flow: $365MQ1'25Q2'25, Free cash flow: −$129MQ2'25Q3'25, Free cash flow: $223MQ3'25Q4'25, Free cash flow: $233MQ4'25Q1'26, Free cash flow: $248MQ1'26Q2'26, Free cash flow: $638MQ2'26−$1.0B−$500M$0$500M$1.0BQ3'22, Free cash flow: $582MQ4'22, Free cash flow: $507MQ4'22Q1'23, Free cash flow: $305MQ2'23, Free cash flow: −$430MQ2'23Q3'23, Free cash flow: $83MQ4'23, Free cash flow: −$786MQ4'23Q1'24, Free cash flow: −$486MQ2'24, Free cash flow: −$84MQ2'24Q3'24, Free cash flow: −$76MQ4'24, Free cash flow: −$347MQ4'24Q1'25, Free cash flow: $365MQ2'25, Free cash flow: −$129MQ2'25Q3'25, Free cash flow: $223MQ4'25, Free cash flow: $233MQ4'25Q1'26, Free cash flow: $248MQ2'26, Free cash flow: $638MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3B$4BQ3'22, Cash and equivalents: $1.4BQ3'22, Long-term debt: $3.1BQ3'22Q4'22, Cash and equivalents: $1.5BQ4'22, Long-term debt: $3.2BQ4'22Q1'23, Cash and equivalents: $1.6BQ1'23, Long-term debt: $3.2BQ1'23Q2'23, Cash and equivalents: $1.6BQ2'23, Long-term debt: $3.5BQ2'23Q3'23, Cash and equivalents: $1.6BQ3'23, Long-term debt: $3.5BQ3'23Q4'23, Cash and equivalents: $890MQ4'23, Long-term debt: $3.5BQ4'23Q1'24, Cash and equivalents: $2.1BQ1'24, Long-term debt: $3.5BQ1'24Q2'24, Cash and equivalents: $1.8BQ2'24, Long-term debt: $3.5BQ2'24Q3'24, Cash and equivalents: $1.7BQ3'24, Long-term debt: $3.6BQ3'24Q4'24, Cash and equivalents: $1.2BQ4'24, Long-term debt: $3.1BQ4'24Q1'25, Cash and equivalents: $1.5BQ1'25, Long-term debt: $3.1BQ1'25Q2'25, Cash and equivalents: $1.8BQ2'25, Long-term debt: $3.2BQ2'25Q3'25, Cash and equivalents: $1.9BQ3'25, Long-term debt: $3.2BQ3'25Q4'25, Cash and equivalents: $1.6BQ4'25, Long-term debt: $3.1BQ4'25Q1'26, Cash and equivalents: $1.1BQ1'26, Long-term debt: $1.8BQ1'26Q2'26, Cash and equivalents: $1.6BQ2'26, Long-term debt: $1.8BQ2'26$0$1B$2B$3B$4BQ3'22, Cash and equivalents: $1.4BQ3'22, Long-term debt: $3.1BQ4'22, Cash and equivalents: $1.5BQ4'22, Long-term debt: $3.2BQ4'22Q1'23, Cash and equivalents: $1.6BQ1'23, Long-term debt: $3.2BQ2'23, Cash and equivalents: $1.6BQ2'23, Long-term debt: $3.5BQ2'23Q3'23, Cash and equivalents: $1.6BQ3'23, Long-term debt: $3.5BQ4'23, Cash and equivalents: $890MQ4'23, Long-term debt: $3.5BQ4'23Q1'24, Cash and equivalents: $2.1BQ1'24, Long-term debt: $3.5BQ2'24, Cash and equivalents: $1.8BQ2'24, Long-term debt: $3.5BQ2'24Q3'24, Cash and equivalents: $1.7BQ3'24, Long-term debt: $3.6BQ4'24, Cash and equivalents: $1.2BQ4'24, Long-term debt: $3.1BQ4'24Q1'25, Cash and equivalents: $1.5BQ1'25, Long-term debt: $3.1BQ2'25, Cash and equivalents: $1.8BQ2'25, Long-term debt: $3.2BQ2'25Q3'25, Cash and equivalents: $1.9BQ3'25, Long-term debt: $3.2BQ4'25, Cash and equivalents: $1.6BQ4'25, Long-term debt: $3.1BQ4'25Q1'26, Cash and equivalents: $1.1BQ1'26, Long-term debt: $1.8BQ2'26, Cash and equivalents: $1.6BQ2'26, Long-term debt: $1.8BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Albemarle Corporation income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed Apr 30, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue1,7431,4291,4281,3081,3301,0771,2321,355+31.1%
Cost of revenue1,1539281,2301,1901,1339211,0941,459+1.8%
Gross profit590501198118197156138(104)+199.8%
Research and development49121312142022−70.5%
Selling, general and administrative126137156139132124136154−4.6%
Operating income453234(217)(217)48204(1,109)+853.0%
Other income (expense)2054(10)29(7)10117(22)+399.3%
Pretax income442254(285)(239)(9)(19)77(1,179)+5023.1%
Income tax9422157(31)34(4)11111+175.7%
Net income480319(414)(161)234175(1,069)+1996.2%
Diluted EPS ($)3.522.34—(1.72)(0.16)0.00—(9.45)+2300.0%
Diluted shares (millions)136119—118118118—118—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Albemarle Corporation balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed Apr 30, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents1,6321,0901,6181,9321,8071,5191,1921,665−9.7%
Short-term investments—————————
Total current assets3,9443,2594,0084,5554,5054,1073,8424,670−12.5%
Total assets15,90515,14016,37417,14817,29216,99916,61017,455−8.0%
Total current liabilities1,8911,5761,7982,0041,9501,9441,9661,911−3.0%
Long-term debt1,8021,8073,1193,1813,1783,1293,1183,566−43.3%
Total liabilities—————————
Stockholders’ equity10,2759,8509,5339,99610,24110,0289,96210,241+0.3%
Shares outstanding (millions)118118118118118118118118—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Albemarle Corporation cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed Apr 30, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow710346388356(9)547(4)227+7965.3%
Capital expenditures7299155132120183343303−40.0%
Free cash flow (CFO − capex)638248233223(129)365(347)(76)+596.1%
Depreciation and amortization156158164164169162163164−7.7%
Share repurchases—————————
Dividends paid4848484848484847+0.1%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 11, 2026.

Income statement

Albemarle Corporation income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 15, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Revenue5,1435,3789,6177,3203,3283,1293,5893,3753,0722,6772,8262,4462,3942,5192,8692,3632,0052,467
Cost of revenue4,4745,3158,4314,2462,3302,1342,3322,1581,9661,707————————
Gross profit669631,1863,0759989951,2581,2171,106970860771850899955742484608
Research and development518786725459587084808988827977586167
Selling, general and administrative550618910524441430533446450354300355158308360275213255
Operating income(367)(1,777)2522,470798506666912572601345271577400518402186221
Other income (expense)2317811186(603)(59)(45)(64)(10)(21)47(17)(7)103(1)1
Pretax income(552)(1,764)2472,433134374563795447515311213538661712527257183
Income tax157874303912954881454329611181348010488(7)(7)
Net income(511)(1,179)1,5732,69012437653369455644335133413312392316178194
Diluted EPS ($)(5.76)(11.20)13.3622.841.063.525.026.340.495.683.001.694.903.474.283.431.942.09
Diluted shares (millions)11811811811811710710610911211311279849092929293

Balance sheet

Albemarle Corporation balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 15, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Cash and equivalents1,6181,1928901,4994397476135551,1372,2702142,490477478469530309253
Short-term investments——————————————————
Total current assets4,0083,8425,2175,1871,9942,2062,2251,9982,4783,3071,8313,3491,4831,4071,3561,3481,032—
Total assets16,37416,61018,27115,45710,97410,4519,8617,5827,7518,1619,5985,2023,5853,4373,2043,0682,772—
Total current liabilities1,7981,9663,5602,7411,8741,8021,4091,1831,2011,1401,6171,140436385401364353—
Long-term debt3,1193,1183,5413,2152,0042,7672,8631,3981,4152,1223,1422,2231,054687749852776—
Total liabilities——————————————————
Stockholders’ equity9,5339,9629,4127,9835,6254,2683,9323,5853,6753,7953,2541,3591,6271,8341,5911,4161,206—
Shares outstanding (millions)11811811711711711710610611111311211279898992——

Cash flow statement

Albemarle Corporation cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 15, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Operating cash flow1,2826881,3271,908344799719546304736361493433489487331359327
Capital expenditures5901,6812,1551,26295485085270031819722811115528119175101100
Free cash flow (CFO − capex)692(993)(828)646(609)(52)(132)(154)(14)539133382278208297256258227
Depreciation and amortization659589430301254232213201197226260104107999796101112
Share repurchases—————005002500015058264178156169
Dividends paid1911891871841781621521451411351198478058504442

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$7M
8 sales by 3 insiders; officers and directors $7M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Wolff Alejandro DanielDirectoraward45$0.00—13,089Oct 2, 2026
Sep 14, 2026Norris EricChief Commercial Officeraward10,867$0.00—64,310Sep 16, 2026
Sep 14, 2026Mummert Mark RichardChief Operations Officeraward6,086$0.00—23,601Sep 16, 2026
Sep 14, 2026Gagarinas Autumn M.Chief People Officeraward5,217$0.00—10,610Sep 16, 2026
Sep 1, 2026Hood MaxChief Accounting Officeraward1,476$0.00—1,476Sep 3, 2026
Jul 21, 2026Desalles Bartolomeo EduardoDirectoraward1,375$0.00—1,375Jul 23, 2026
Jul 1, 2026Collins Michelle TDirectoraward1,250$0.00—1,575Jul 6, 2026
Jul 1, 2026Collins Michelle TDirectoraward2$0.00—1,577Jul 6, 2026
Jul 1, 2026Cramer Ralf HansDirectoraward1,250$0.00—6,629Jul 6, 2026
Jul 1, 2026Cramer Ralf HansDirectortax withholding929$136.08$126K5,700Jul 6, 2026
Jul 1, 2026Cramer Ralf HansDirectoraward36$0.00—5,736Jul 6, 2026
Jul 1, 2026Cramer Ralf HansDirectortax withholding13$136.08$2K5,723Jul 6, 2026
Jul 1, 2026Brlas LaurieDirectoraward1,250$0.00—7,253Jul 6, 2026
Jul 1, 2026Brlas LaurieDirectoraward36$0.00—7,289Jul 6, 2026
Jul 1, 2026Wolff Alejandro DanielDirectoraward33$0.00—13,044Jul 6, 2026
Jul 1, 2026Steiner Gerald ADirectoraward1,250$0.00—13,196Jul 6, 2026
Jul 1, 2026Steiner Gerald ADirectoraward36$0.00—13,232Jul 6, 2026
Jul 1, 2026OConnell Diarmuid B.Directoraward1,250$0.00—8,590Jul 6, 2026
Jul 1, 2026OConnell Diarmuid B.Directoraward36$0.00—8,626Jul 6, 2026
May 15, 2026Masters J KentChairman & CEO, Directoropen-market sale3,826$183.12$701K100,086May 19, 2026
May 15, 2026Masters J KentChairman & CEO, Directoropen-market sale11,867$183.87$2M88,219May 19, 2026
May 15, 2026Masters J KentChairman & CEO, Directoropen-market sale700$184.52$129K87,519May 19, 2026
Apr 1, 2026Wolff Alejandro DanielDirectoraward25$0.00—13,011Apr 2, 2026
Mar 12, 2026Masters J KentChairman & CEO, Directorgift30,716$162.79$5M103,912Mar 12, 2026
Mar 10, 2026Masters J KentChairman & CEO, Directoropen-market sale5,395$170.26$919K141,016Mar 12, 2026

Full insider history for Albemarle Corporation, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
ALBEMARLE CORPORATION, CIK 915913 on EDGAR
Extract generated
November 4, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: pretax income FY2010, revenue FY2012, opex sga FY2015
Repaired
4 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2014, income tax FY2015, other income FY2015, gross profit FY2023
XBRL concepts behind each line

Income statement

Revenue: Revenues, SalesRevenueNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/ALB.json